| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 112.472 | 150.949 | 217.051 | 188.962 | 140.820 | 138.513 | 196.334 | 242.614 | 172.235 | 177.136 |
| Total Income - EUR | 114.704 | 154.374 | 230.992 | 206.345 | 162.390 | 151.692 | 199.925 | 268.154 | 180.048 | 181.147 |
| Total Expenses - EUR | 101.889 | 140.240 | 142.963 | 155.687 | 137.772 | 116.918 | 141.478 | 182.099 | 172.786 | 164.196 |
| Gross Profit/Loss - EUR | 12.815 | 14.134 | 88.030 | 50.658 | 24.617 | 34.773 | 58.447 | 86.055 | 7.262 | 16.952 |
| Net Profit/Loss - EUR | 10.697 | 11.748 | 79.863 | 48.682 | 23.223 | 33.555 | 56.629 | 83.694 | 5.773 | 12.814 |
| Employees | 2 | 3 | 4 | 4 | 4 | 4 | 6 | 6 | 4 | 4 |
Check the financial reports for the company - Alvaliv Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 84.148 | 190.899 | 198.978 | 196.361 | 228.952 | 219.608 | 211.210 | 246.747 | 273.519 | 256.065 |
| Current Assets | 12.053 | 29.314 | 31.204 | 54.831 | 46.221 | 82.921 | 41.125 | 25.998 | 20.880 | 25.440 |
| Inventories | 1.067 | 9.969 | 7.659 | 3.224 | 12.781 | 17.832 | 24.778 | 12.515 | 11.208 | 14.196 |
| Receivables | 5.321 | 17.282 | 9.259 | 18.996 | 8.571 | 15.390 | 10.140 | 7.502 | 3.653 | 7.058 |
| Cash | 5.665 | 2.063 | 14.286 | 32.611 | 24.869 | 49.699 | 6.207 | 5.981 | 6.020 | 4.186 |
| Shareholders Funds | 37.294 | 78.882 | 130.616 | 117.732 | 138.632 | 169.558 | 157.995 | 182.414 | 185.435 | 197.213 |
| Social Capital | 14.508 | 44.580 | 43.826 | 43.021 | 42.188 | 41.388 | 40.471 | 40.596 | 40.473 | 40.247 |
| Debts | 58.907 | 141.332 | 99.565 | 133.460 | 136.542 | 132.971 | 94.339 | 90.331 | 108.964 | 84.293 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3811 - 3811" | |||||||||
| CAEN Financial Year |
3811
|
|||||||||
Comments - Alvaliv Srl